+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Antimicrobial Resistance Diagnostic Market by Technology (Mass Spectrometry, Microarray, Next Generation Sequencing), Product (Instruments, Reagents & Consumables, Software & Services), Test Type, End User, Application, Sample Type, Pathogen - Global Forecast 2025-2030- Product Image
Antimicrobial Resistance Diagnostic Market by Technology (Mass Spectrometry, Microarray, Next Generation Sequencing), Product (Instruments, Reagents & Consumables, Software & Services), Test Type, End User, Application, Sample Type, Pathogen - Global Forecast 2025-2030- Product Image
Sale

Antimicrobial Resistance Diagnostic Market by Technology (Mass Spectrometry, Microarray, Next Generation Sequencing), Product (Instruments, Reagents & Consumables, Software & Services), Test Type, End User, Application, Sample Type, Pathogen - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6014956
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The antimicrobial resistance diagnostic market is entering a critical period of accelerated demand, driven by heightened global awareness of resistance challenges and a renewed focus on rapid, actionable diagnostic solutions. Senior decision-makers require robust, fact-based insights to guide strategy in a sector shaped by continued technological breakthroughs and growing supply chain complexities.

Market Snapshot: Antimicrobial Resistance Diagnostic Market Growth (Primary Keyword)

The Antimicrobial Resistance Diagnostic Market grew from USD 4.75 billion in 2024 to USD 5.07 billion in 2025. It is expected to continue growing at a CAGR of 6.35%, reaching USD 6.88 billion by 2030. This sustained expansion reflects the urgency for advanced detection tools, evolving regulatory expectations, and increased investment in resistance management capabilities across healthcare, research, and biopharmaceutical settings.

Scope & Segmentation

  • Technology: Mass spectrometry, microarray, next generation sequencing (long and short read), polymerase chain reaction (PCR).
  • Product: Instruments, reagents and consumables, software and services, including consulting and support services.
  • Test Type: Genotypic tests (targeted assays and whole genome sequencing), phenotypic tests.
  • End User: Academic and research institutions, diagnostic centers, hospitals and clinics, reference laboratories.
  • Application: Human diagnostics, pharmaceutical and biopharmaceutical, veterinary diagnostics.
  • Sample Type: Blood, respiratory, urine, wound swabs.
  • Pathogen: Fungi, gram negative bacteria, gram positive bacteria.
  • Region: Americas (including the United States, Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (covering United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland); Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Leading Companies: Roche Diagnostics, Abbott Laboratories, Thermo Fisher Scientific Inc., bioMérieux SA, Danaher Corporation, Becton, Dickinson and Company, QIAGEN N.V., Siemens Healthineers AG, Bruker Corporation, Bio-Rad Laboratories, Inc.

Key Takeaways

  • Advanced diagnostic platforms now play a pivotal role in enabling timely clinical decisions and supporting antimicrobial stewardship initiatives.
  • Innovations in sequencing, miniaturization, and automation are rapidly expanding the accessibility and performance of resistance detection across settings.
  • Point-of-care and decentralized models are empowering frontline healthcare providers, improving diagnostics reach and care integration beyond centralized laboratories.
  • AI and machine learning technologies are streamlining analysis of complex data sets, supporting faster turnaround and enhanced accuracy in resistance profiling.
  • Collaborative partnerships among healthcare, technology, and regulatory stakeholders are increasingly vital for standardizing practices and driving sustainable adoption.
  • Supply diversification and manufacturing localization are emerging as crucial strategies for resilience in an evolving market landscape.

Tariff Impact: U.S. 2025 Supply Chain Disruptions

United States tariff policies introduced in 2025 have imposed elevated duties on reagents, instruments, and key components essential for resistance testing. This has increased procurement costs for laboratories and manufacturers. The resulting pressures have led organizations to revisit sourcing, prioritize local partners, and focus on supply chain agility. Stakeholders are adapting procurement workflows to ensure business continuity and value optimization amid evolving fiscal challenges.

Methodology & Data Sources

This report utilizes a multi-tier research framework, combining primary interviews with clinical experts and industry leaders, and systematic reviews of peer-reviewed literature, regulatory filings, and proprietary datasets. Segmentation was validated with subject matter experts to ensure accuracy and operational relevance.

Why This Report Matters

  • Enables senior decision-makers to identify actionable growth opportunities by segment, region, and technology.
  • Supports strategic planning for supply chain resilience and regulatory compliance in an evolving global environment.
  • Delivers fact-based insights for investment, innovation, and partnership development to sustain leadership in resistance diagnostics.

Conclusion

The antimicrobial resistance diagnostic sector is advancing rapidly, shaped by technological innovation and global policy trends. Leaders equipped with in-depth, segmented market intelligence can confidently navigate strategic decisions in this high-impact domain.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of artificial intelligence algorithms in rapid antimicrobial resistance diagnostics to improve accuracy and turnaround time
5.2. Adoption of point-of-care multiplex polymerase chain reaction panels for on-site detection of resistant pathogens in outpatient settings
5.3. Implementation of next-generation sequencing platforms in clinical labs for comprehensive AMR gene profiling and surveillance
5.4. Expansion of CRISPR-Cas based biosensor technologies for highly specific and sensitive detection of resistance markers at point of need
5.5. Development of decentralized molecular diagnostic devices for antimicrobial resistance testing in low-resource and remote healthcare facilities
5.6. Increasing collaboration between public health authorities and diagnostic manufacturers for integrated AMR surveillance networks
5.7. Emergence of rapid phage susceptibility testing methodologies to guide personalized antimicrobial therapy within hours
5.8. Strengthening regulatory pathways and reimbursement frameworks to accelerate commercialization of novel AMR diagnostic assays
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Antimicrobial Resistance Diagnostic Market, by Technology
8.1. Introduction
8.2. Mass Spectrometry
8.3. Microarray
8.4. Next Generation Sequencing
8.4.1. Long Read Sequencing
8.4.2. Short Read Sequencing
8.5. Polymerase Chain Reaction (PCR)
9. Antimicrobial Resistance Diagnostic Market, by Product
9.1. Introduction
9.2. Instruments
9.3. Reagents & Consumables
9.4. Software & Services
9.4.1. Services
9.4.1.1. Consulting Services
9.4.1.2. Support Services
9.4.2. Software
10. Antimicrobial Resistance Diagnostic Market, by Test Type
10.1. Introduction
10.2. Genotypic Tests
10.2.1. Targeted Assays
10.2.2. Whole Genome Sequencing
10.3. Phenotypic Tests
11. Antimicrobial Resistance Diagnostic Market, by End User
11.1. Introduction
11.2. Academic & Research Institutions
11.3. Diagnostic Centers
11.4. Hospitals & Clinics
11.5. Reference Laboratories
12. Antimicrobial Resistance Diagnostic Market, by Application
12.1. Introduction
12.2. Human Diagnostics
12.3. Pharmaceutical & Biopharmaceutical
12.4. Veterinary Diagnostics
13. Antimicrobial Resistance Diagnostic Market, by Sample Type
13.1. Introduction
13.2. Blood Samples
13.3. Respiratory Samples
13.4. Urine Samples
13.5. Wound Swabs
14. Antimicrobial Resistance Diagnostic Market, by Pathogen
14.1. Introduction
14.2. Fungi
14.3. Gram Negative Bacteria
14.4. Gram Positive Bacteria
15. Americas Antimicrobial Resistance Diagnostic Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Antimicrobial Resistance Diagnostic Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Antimicrobial Resistance Diagnostic Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Roche Diagnostics
18.3.2. Abbott Laboratories
18.3.3. Thermo Fisher Scientific Inc.
18.3.4. bioMérieux SA
18.3.5. Danaher Corporation
18.3.6. Becton, Dickinson and Company
18.3.7. QIAGEN N.V.
18.3.8. Siemens Healthineers AG
18.3.9. Bruker Corporation
18.3.10. Bio-Rad Laboratories, Inc.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024 VS 2030 (%)
FIGURE 18. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET: RESEARCHAI
FIGURE 30. ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET: RESEARCHSTATISTICS
FIGURE 31. ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET: RESEARCHCONTACTS
FIGURE 32. ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY MICROARRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LONG READ SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LONG READ SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SHORT READ SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SHORT READ SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SUPPORT SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SUPPORT SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TARGETED ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TARGETED ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PHENOTYPIC TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PHENOTYPIC TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY HUMAN DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY HUMAN DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY VETERINARY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY VETERINARY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY BLOOD SAMPLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY BLOOD SAMPLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY SAMPLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY SAMPLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY URINE SAMPLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY URINE SAMPLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY WOUND SWABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY WOUND SWABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FUNGI, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FUNGI, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GRAM NEGATIVE BACTERIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GRAM NEGATIVE BACTERIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GRAM POSITIVE BACTERIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GRAM POSITIVE BACTERIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 141. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 142. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 143. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 144. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 145. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 146. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 147. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 148. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 149. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 150. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 151. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 152. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 153. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2018-2024 (USD MILLION)
TABLE 154. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2025-2030 (USD MILLION)
TABLE 155. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 160. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 161. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2024 (USD MILLION)
TABLE 162. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2025-2030 (USD MILLION)
TABLE 163. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 164. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 165. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 166. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 167. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 168. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 169. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 170. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 171. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 172. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 173. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 174. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 175. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2018-2024 (USD MILLION)
TABLE 176. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2025-2030 (USD MILLION)
TABLE 177. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 182. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 183. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2024 (USD MILLION)
TABLE 184. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GENOTYPIC TESTS, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2025-2030 (USD MILLION)
TABLE 275. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 276. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 277. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 278. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 279. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 280. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 281. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 282. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 283. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 284. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 285. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 286. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 287. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY GEN

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Antimicrobial Resistance Diagnostic market report include:
  • Roche Diagnostics
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • Danaher Corporation
  • Becton, Dickinson and Company
  • QIAGEN N.V.
  • Siemens Healthineers AG
  • Bruker Corporation
  • Bio-Rad Laboratories, Inc.

Table Information

Report AttributeDetails
No. of Pages198
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 5.07 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.88 Billion
Compound Annual Growth Rate6.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Antimicrobial Resistance Surveillance Market by Offering (Consumables And Reagents, Instruments, Services), Technology (Automated AST Systems, Manual AST, Mass Spectrometry), Application, End User - Global Forecast 2025-2030 - Product Image

Antimicrobial Resistance Surveillance Market by Offering (Consumables And Reagents, Instruments, Services), Technology (Automated AST Systems, Manual AST, Mass Spectrometry), Application, End User - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Antimicrobial Resistance Diagnostics Market Size, Share & Trends Analysis Report by Technology (Microbiology Culture, PCR), End-use (Hospitals, Diagnostic Laboratories), Pathogen, Region, and Segment Forecasts, 2025-2030 - Product Image

Antimicrobial Resistance Diagnostics Market Size, Share & Trends Analysis Report by Technology (Microbiology Culture, PCR), End-use (Hospitals, Diagnostic Laboratories), Pathogen, Region, and Segment Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Antimicrobial Resistance Diagnostics - Global Strategic Business Report - Product Image

Antimicrobial Resistance Diagnostics - Global Strategic Business Report

  • Report
  • 281 Pages
  • Global
From
Antimicrobial Resistance Surveillance - Global Strategic Business Report - Product Image

Antimicrobial Resistance Surveillance - Global Strategic Business Report

  • Report
  • 377 Pages
  • Global
From
Antibiotic Resistance Market by Offering (Combination Therapies, Drugs, Immunomodulators), Pathogen Type (Acinetobacter Paumannii (A. baumannii), Escherichia Coli (E. coli), Klebsiella Pneumoniae (K. pneumoniae)), Infection Type, End Use - Global Forecast 2025-2030 - Product Image

Antibiotic Resistance Market by Offering (Combination Therapies, Drugs, Immunomodulators), Pathogen Type (Acinetobacter Paumannii (A. baumannii), Escherichia Coli (E. coli), Klebsiella Pneumoniae (K. pneumoniae)), Infection Type, End Use - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.